Filderstadt, Germany

Ursula Dahn

This inventor holds 2 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 1977-1979.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ursula Dahn. Retrieved from https://idiyas.com/inventor/ursula-dahn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1977-1979

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ursula Dahn: Innovator in Antibiotic Development

Introduction

Ursula Dahn is a notable inventor based in Filderstadt, Germany. She has made significant contributions to the field of antibiotic development, particularly through her work with the strain Streptomyces tendae Ettlinger. With a total of 2 patents, her innovations have the potential to impact the medical community significantly.

Latest Patents

Dahn's latest patents include a fungicidally active antibiotic derived from Streptomyces tendae Ettlinger. The new antibiotic, Nikkomycin, is produced by culturing the strain in a nutrient medium at a pH of about 5.5 to 8 under aerobic conditions. The isolation process involves cation exchange from the culture filtrate, followed by elution. This antibiotic is characterized by its structural formula and is noted for its fungicidal activity.

Career Highlights

Ursula Dahn is currently associated with Bayer Aktiengesellschaft, where she continues her research and development in antibiotics. Her work has been instrumental in advancing the understanding and application of fungicidal agents in medicine.

Collaborations

Dahn has collaborated with notable colleagues, including Hanspaul Hagenmaier and Helmut Hohne. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Ursula Dahn's contributions to antibiotic development exemplify the importance of innovation in healthcare. Her work not only enhances our understanding of antibiotics but also paves the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…